Analyst Research Report Snapshot

Title:

Oxford BioMedica Plc

Price:

$50.00

Provider:

MarketLine (a Datamonitor Company)

Date:

28 Aug 2013

Pages:

33

Type:

AcrobatPDF

Companies referenced:

OXB.L

Available for Immediate Download
Summary:

Oxford BioMedica Plc - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Oxford BioMedica Plc required for business and competitor intelligence needs - Intelligence on Oxford BioMedica Plc’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Oxford BioMedica Plc, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Oxford BioMedica is a biopharmaceutical company, engaged in developing gene-based medicines and therapeutic vaccines. The company’s technology platform includes the LentiVector gene delivery technology that targets the diseases of the central nervous system and the eyes; and a unique tumor antigen (5T4), an ideal target for anti-cancer therapy. The company operates in the US and the UK. It is headquartered in Oxford, the UK and employs around 81 people. The company recorded revenues of £7.8 million (approximately $12.3 million) in the fiscal year ended December 2012, an increase of 0.5% over 2011. The company's operating loss was £10.5 million (approximately $16.6 million) in fiscal 2012, as compared to an operating loss of £14.4 million (approximately $22.9million) in 2011. Its net loss was £8.7 million (approximately $13.8 million) in fiscal 2012, as compared to the net loss of £12.6 million (approximately $20 million) in 2011. Reasons to Purchase: - Gain understanding of Oxford BioMedica Plc the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Oxford BioMedica Plc as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Oxford BioMedica Plc your competitors' business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.